Response to Cembrowski et al. regarding "Could susceptibility to low hematocrit interference have compromised the results of the NICE-SUGAR trial?"
- PMID: 20675612
- DOI: 10.1373/clinchem.2010.150995
Response to Cembrowski et al. regarding "Could susceptibility to low hematocrit interference have compromised the results of the NICE-SUGAR trial?"
Comment on
-
Could susceptibility to low hematocrit interference have compromised the results of the NICE-SUGAR trial?Clin Chem. 2010 Jul;56(7):1193-5. doi: 10.1373/clinchem.2010.146217. Epub 2010 Apr 29. Clin Chem. 2010. PMID: 20431051 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
